Law360, New York (April 13, 2010, 5:09 PM ET) -- Endo Pharmaceuticals Inc. and Penwest Pharmaceuticals Co. said Tuesday they had agreed to a settlement in their patent infringement suit against Barr Laboratories Inc. over the production and sale of a generic version of painkiller Opana ER.
According to a letter posted in the U.S. District Court for the District of New Jersey, the parties have reached an amicable settlement.
Chadds Ford, Pa.-based Endo said in a statement Tuesday that, under the terms of the deal, the plaintiffs would grant Barr a license to sell a...
Endo, Penwest Reach Opana License Deal With Barr
To view the full article, take a free trial now.
